1
|
Foinard A, Perez M, Barthélémy C, Lannoy D, Flamein F, Storme L, Tournoys A, Décaudin B, Odou P. Assessment of anti-factor Xa activity of heparin in binary parenteral nutrition admixtures for premature neonates. Ann Pharm Fr 2015; 73:277-80. [PMID: 25863599 DOI: 10.1016/j.pharma.2015.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2014] [Revised: 03/09/2015] [Accepted: 03/11/2015] [Indexed: 11/30/2022]
Abstract
An in vitro study was carried out to determine the anti-Xa activity of heparin in binary parenteral nutrition (BPN) admixtures for premature neonates in our neonatal intensive care unit (NICU) after a 24-hour infusion, as well as to assess drug interaction with a 50% glucose solution. Two types of bags were prepared: (1) BPN admixtures (composition defined in the NICU) including sodium heparin at 77 UI/mL and (2) bags containing only G50% with sodium heparin at 193 UI/mL. The anti-Xa activity of heparin was measured in bags at T0, after the 24-hour infusion and in eluates at the outlet of the infusion line after 24hours, using a validated chromogenic anti-Xa method. Comparisons of the mean concentration observed with the theoretical value for anti-Xa activity were performed with the Student t-test. Mean values of anti-Xa activity do not differ significantly from the values expected for all conditions. We found a slight variation in anti-Xa activity when infused over 24hours for both types of bags, with and without in-line filtration, showing that heparin remains stable during this infusion period in both BPN admixtures and G50%.
Collapse
Affiliation(s)
- A Foinard
- EA GRITA, laboratoire de biopharmacie, pharmacie galénique et hospitalière, université Lille Nord de France, 3, rue du Professeur-Laguesse, BP 83, 59006 Lille cedex, France; Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59037 Lille cedex, France
| | - M Perez
- EA GRITA, laboratoire de biopharmacie, pharmacie galénique et hospitalière, université Lille Nord de France, 3, rue du Professeur-Laguesse, BP 83, 59006 Lille cedex, France; Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59037 Lille cedex, France
| | - C Barthélémy
- EA GRITA, laboratoire de biopharmacie, pharmacie galénique et hospitalière, université Lille Nord de France, 3, rue du Professeur-Laguesse, BP 83, 59006 Lille cedex, France
| | - D Lannoy
- EA GRITA, laboratoire de biopharmacie, pharmacie galénique et hospitalière, université Lille Nord de France, 3, rue du Professeur-Laguesse, BP 83, 59006 Lille cedex, France; Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59037 Lille cedex, France
| | - F Flamein
- Service de néonatalogie, hôpital Jeanne-de-Flandre, CHRU de Lille, 2 avenue Oscar-Lambret, 59037 Lille cedex, France
| | - L Storme
- Service de néonatalogie, hôpital Jeanne-de-Flandre, CHRU de Lille, 2 avenue Oscar-Lambret, 59037 Lille cedex, France; EA4489, laboratoire environnement périnatal et santé, université Lille Nord de France, 1, place de Verdun, 59045 Lille cedex, France
| | - A Tournoys
- Laboratoire d'hématologie, centre de biologie pathologie, CHRU de Lille, boulevard du Professeur-Jules-Leclercq, 59037 Lille cedex, France
| | - B Décaudin
- EA GRITA, laboratoire de biopharmacie, pharmacie galénique et hospitalière, université Lille Nord de France, 3, rue du Professeur-Laguesse, BP 83, 59006 Lille cedex, France; Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59037 Lille cedex, France.
| | - P Odou
- EA GRITA, laboratoire de biopharmacie, pharmacie galénique et hospitalière, université Lille Nord de France, 3, rue du Professeur-Laguesse, BP 83, 59006 Lille cedex, France; Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59037 Lille cedex, France
| |
Collapse
|